A recovery-oriented approach to psychiatric medication: Guidelines for nurses

Journal of Psychosocial Nursing and Mental Health Services

Volumn 45, Issue 2, 2007, Pages 35-40

  Roe, David ^a   Swarbrick, Margaret ^b,c  

^a UNIVERSITY OF HAIFA   (Israel)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947185853     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20070201-07     Document Type: Review

References (24)

1. Bollini, P., Tibaldi, G., Testa, C., & Munizza, C. (2004). Understanding treatment adherence in affective disorders: A qualitative study. Journal of Psychiatric and Menla! Health Nursing, 11, 668-674.
2. Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: What does it mean? (Or it takes at least two to tango). Social Science & Medicine, 44, 681-692.
3. Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286-290.
4. Copeland, M.E. (2002). Wellness recovery ocrion plan. West Dummerston, VT: Peach Press.
5. Day, J.C., Bentall, R.P., Roberts, C., Randall, F., Rogers, A., Cattell, D., et al. (2005). Attitudes toward antipsychotic medication: The impact of clinical variables and relationships with health professionals. Archives of General Psychiatry, 62, 717-724.
6. Deegan, P.E. (2005). The importance of personal medicine: A qualitative study of resilience in people with psychiatric disabilities. Scandinavian Journal of Public Health. Supplement, 66, 29-35.
7. Edwards, A., & Elwyn, G. (Eds.). (2001). Evidence-hosed patient choice. New York: Oxford University Press.
8. Fenton, W.S., Blyler, C.R., & Heinssen, R.K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23, 637-651.
9. Fleck, D.E., Keck P.E., Jr., Corey, K.B., & Strakowski, S.M. (2005). Factors associated with medication adherence in African American and white patients with bipolar disorder. Journal of Clinical Psychiatry, 66, 646-652.
10. Freudenreich, O., Cather, C., Evins, A.E., Henderson, D.C., & Goff, D.C. (2004). Attitudes of schizophrenia outpatients toward psychiatric medications: Relationship to clinical variables and insight. Journal of Clinical Psychiatry, 10, 1372-1376.
11. Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., et al. (2004). Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry, 19, 415-422.
12. Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105, 164-172.
13. Mueser, K.T., Corrigan, P.W., Hilton, D.W., Tanzman, B., Schaub, A., Gingerich, S., et al. (2002). Illness management and recovery: A review of the research. Psychiatric Services, 53, 1272-1284.
14. Nose, M., Barbui, C., & Tansella, M. (2003). How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine, 33, 1149-1160.
15. O'Connor, A.M., Stacey, D., Entwistle, V., Llewellyn-Thomas, H., Rovner, D., Holmes-Rovner, M., et al. (2003). Decision aids for people facing health treatment or screening decisions (Cochrane review). In The Cochrane Database of Systematic Reviews, Issue 1. Oxford, UK: Wiley & Sons.
16. Olfson, M., Marcus, S.C., Wilk, J., & West, J.C. (2006). Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatric Services, 57, 205-211.
17. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1982). Making health care decisions: The ethical and legal implications of informed consent in the patient-practitioner relationship. Washington, DC: Author.
18. Substance Abuse & Mental Health Services Administration. (2005). Transforming mental health care in America: The federal action agenda: First steps. Rockville, MD: Author.
19. Thomley, B., & Adams, C. (1998). Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ, 317, 1181-1184.
20. Towle, A., & Godolphin, W. (1999). Framework for teaching and learning informed shared decision making. BMJ, 319, 766-771.
21. Verdoux, H., Lengronne, J., Liraud, F., Gonzales, B., Assens, F., Abalan, F., et al. (2000). Medication adherence in psychosis: Predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica, 102, 203-210.
22. Voils, C.I., Steffens, D.C., Flint, E.P., & Bosworth, H.B. (2005). Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. American Journal of Geriatric Psychiatry, 3, 157-165.
23. Yen, C.F., Chen, C.S., Ko, C.H., Yeh, M.L., Yang, S.J., Yen, J.Y., et al. (2005). Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study. Psychiatry and Clinical Neurosciences, 59, 403-409.
24. Zygmunt, A., Olfson, M., Boyer, C.A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159, 1653-1664.